Kiadis Pharma Terug naar discussie overzicht

Molmed versus Kiadis Pharma en aanverwante biotech aandelen

1. MG76 17 maart 2020 12:36

   auteur info

   • MG76

     Lid sinds: 20 aug 2016

     Laatste bezoek: 21 mei 2023

   • Aanbevelingen

     Ontvangen: 22

     Gegeven: 66

   •    Aantal posts: 200

   Overname bod op molmed van 0.518 euro
   
   Japan's AGC launches bid on Italy's Molmed worth up to 240 mln euros
   Contributor
   3-4 minuten
   
   Published
   
   Mar 17, 2020 3:18AM EDT
   
   Japan's AGC has launched a takeover bid on all the shares of Italian biotech company Molmed in a deal worth up to 240 million euros ($267 million), AGC said in a statement on Tuesday.
   
   MILAN, March 17 (Reuters) - Japan's AGC 5201.T has launched a takeover bid on all the shares of Italian biotech company Molmed MLMD.MI in a deal worth up to 240 million euros ($267 million), AGC said in a statement on Tuesday.
   
   AGC is offering 0.518 euros per Molmed share, the equivalent of a premium of 110.3%.
   
   AGC said Fininvest, the holding company of the family of former Prime Minister Silvio Berlusconi, had agreed to tender its stake in Molmed.
   
   Fininvest owns around 23% of Molmed shares.
   
   The aim of the bid is to delist Molmed, AGC said.
2. [verwijderd] 18 maart 2020 19:21

   auteur info

   • [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   • Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Alles nu gericht op de medische zorg. Geld te over zo hoor ik meneer Rutte.